TSS:Rfhg 237882.1

Basic information about the TSS

---

TSS ID: rfhg_237882.1 Species: human Chr: chrX		Start: 103676612 End: 103676613 Strand: -
Source datasets	PRJNA401781
Protocol	oligo_capping
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: CU691178:-413 GeneID: 9643 HGNC/MGI_ID: HGNC:16849 UniProt_ID: Nearer transcript ids and distances: EU832807:-414 GQ129427:-414 AB383713:-414 EU446748:-414 view more...

Gene_name: mortality factor 4 like 2 Gene_symbol: MORF4L2 Gene_synonyms: KIAA0026 MRGX Gene_source: HGNC:16849

TATA-Box annotation

---

Distance to TSS:	10087
Nearest PromoterID:	NM_012286
Entrez ID:	9643
Nearest Unigene:	Hs.326387
Nearest Refseq:	NM_012286
Nearest Ensembl:	ENSG00000123562
Gene Name:	mortality factor 4 like 2
Gene Alias:	MORFL2|MRGX
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MORF4L2 p2@MORF4L2 p3@MORF4L2 p4@MORF4L2 p5@MORF4L2
Sample		p1@MORF4L2	p2@MORF4L2	p3@MORF4L2	p4@MORF4L2	p5@MORF4L2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	120.97	2.73	0.19	0.19	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	120.38	3.84	0.20	0.40	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	129.63	3.47	0.00	0.19	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	118.09	2.49	0.42	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	108.88	2.02	0.00	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	131.02	2.71	0.19	0.19	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	196.75	10.68	0.22	0.65	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	147.51	5.33	0.73	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	120.11	5.56	0.43	1.07	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	94.48	1.16	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	99.04	5.26	0.00	1.21	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	106.92	3.66	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	63.19	16.28	0.64	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	70.51	15.94	1.35	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	58.84	15.81	0.88	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	54.57	14.33	2.01	1.26	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	57.44	16.16	1.09	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	59.90	16.45	2.11	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	60.25	15.46	1.07	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	67.40	14.74	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	62.01	16.04	1.20	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	74.57	18.13	0.52	0.69	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	70.19	18.10	0.78	0.26	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	57.75	14.56	0.73	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	62.43	19.87	1.03	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	50.33	18.67	0.63	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	54.40	15.38	0.00	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	86.99	16.03	0.00	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	55.40	10.34	0.65	0.65	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	78.72	14.12	1.27	1.09	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	65.73	15.07	0.84	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	57.83	12.11	1.17	0.00	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	66.69	12.24	1.06	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	113.97	21.11	0.66	0.49	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	72.55	16.08	0.56	0.19	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	74.16	13.03	0.96	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	72.15	14.51	1.23	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	69.11	11.69	0.20	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	74.82	10.80	1.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	73.22	10.32	0.48	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	70.11	10.82	1.65	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	92.23	16.54	1.61	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	72.34	12.44	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	75.88	13.29	1.22	0.87	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	79.51	12.65	0.80	0.40	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	81.89	16.05	1.40	0.00	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	77.01	10.32	0.48	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	75.41	12.52	1.19	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	84.98	11.49	0.24	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	87.55	12.33	1.01	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	91.82	13.73	0.82	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	103.85	16.68	0.67	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	3330.14	279.84	13.99	0.00	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	78.42	14.19	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	100.08	16.90	0.99	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	663.60	83.89	5.87	3.36	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	235.59	23.42	1.84	0.46	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	104.04	18.47	1.94	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	82.22	13.17	0.00	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	220.35	33.32	2.20	1.26	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	76.15	14.81	0.71	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	78.51	18.51	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	300.15	39.01	1.59	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	153.91	18.01	2.04	0.34	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	99.10	14.62	1.30	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	84.13	12.78	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	3475.25	452.59	32.33	32.33	64.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	3064.22	418.57	15.79	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	102.87	19.50	0.49	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	104.13	22.81	0.99	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	114.46	20.64	0.94	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	131.15	20.20	1.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	98.99	19.49	1.24	0.00	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	86.22	19.26	0.92	0.92	0.92
Adipocyte - breast, donor1	11376-118A8	598.06	48.62	3.01	0.79	1.43
Adipocyte - breast, donor2	11327-117E4	274.81	21.18	2.09	0.32	3.69
Adipocyte - omental, donor1	11473-119C6	744.03	56.23	5.73	1.27	2.16
Adipocyte - omental, donor2	11474-119C7	453.73	12.71	1.49	0.00	3.74
Adipocyte - omental, donor3	11475-119C8	523.48	18.09	2.68	0.00	1.67
Adipocyte - perirenal, donor1	11476-119C9	542.93	30.62	0.64	1.28	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	199.01	16.49	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	219.94	14.00	2.71	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	70.55	13.38	1.39	0.35	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	267.93	19.95	2.35	0.78	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	155.20	12.87	1.03	0.51	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	137.71	19.24	1.67	0.84	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	116.39	32.33	2.35	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	178.80	29.04	2.01	0.64	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	113.93	24.21	1.61	0.97	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	105.04	23.46	0.00	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	115.74	22.81	1.67	0.56	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	76.94	17.05	0.42	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	88.41	19.84	1.51	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	85.74	16.04	2.29	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	69.42	16.14	1.83	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	157.13	7.07	0.00	0.88	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	16.14	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	244.85	11.51	1.44	0.18	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	66.94	5.02	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	146.48	5.75	0.41	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	348.20	43.48	4.81	0.23	0.34
Anulus Pulposus Cell, donor2	11463-119B5	138.62	13.47	1.71	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	189.15	13.48	1.80	0.00	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	172.35	17.80	1.30	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	154.10	21.40	2.14	2.14	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	173.08	16.74	0.90	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	161.88	16.44	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	106.93	14.52	0.66	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	161.79	14.29	0.32	0.32	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	178.64	14.08	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	154.41	22.57	0.59	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	207.90	15.82	1.88	0.75	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	185.77	18.87	0.73	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	106.57	10.03	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	214.16	16.97	2.47	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	171.96	10.92	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	165.87	17.49	2.41	0.90	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	163.95	15.00	2.14	1.61	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	156.25	17.19	0.94	0.76	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	147.27	15.77	1.60	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	156.07	9.75	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	161.71	17.75	1.33	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	141.69	7.20	1.20	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	155.77	10.62	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	153.86	12.35	1.72	0.17	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	130.04	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	183.49	12.62	2.43	2.43	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	174.17	17.08	1.90	1.14	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	115.08	23.02	0.00	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	205.21	17.10	2.28	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	150.93	15.18	1.50	0.43	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	105.82	13.42	1.29	0.52	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	167.04	11.26	2.35	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	124.12	14.47	1.29	0.32	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	117.72	20.69	0.71	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	136.88	15.79	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	146.62	11.74	0.30	0.30	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	128.30	15.44	1.19	0.00	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	171.38	20.34	1.02	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	160.71	19.61	1.53	0.25	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	107.38	13.98	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	156.22	17.26	1.29	0.00	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	158.76	17.15	1.91	1.06	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	117.73	13.92	0.87	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	144.54	9.45	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	138.50	16.27	1.19	0.17	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	129.72	16.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	173.23	8.45	2.11	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	146.87	13.29	1.50	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	135.37	10.83	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	183.70	12.39	2.19	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	174.25	18.85	2.07	0.46	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	150.47	15.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	201.61	18.81	1.27	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	183.94	20.64	2.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	123.01	15.61	1.84	0.92	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	222.28	18.16	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	164.31	17.30	1.77	0.22	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	149.53	27.46	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	185.00	12.19	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	145.37	16.42	0.79	0.26	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	134.84	11.99	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	172.43	6.63	1.11	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	51.18	2.05	0.17	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	20.56	4.19	0.21	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	245.06	26.49	1.39	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	249.94	13.43	2.26	0.49	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	231.65	13.57	1.94	0.75	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	171.34	16.51	1.03	0.11	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	171.64	16.04	0.63	0.13	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	161.70	18.55	0.46	0.23	0.57
Basophils, donor1	12241-129G9	72.44	7.58	0.00	0.00	0.00
Basophils, donor2	12242-129H1	135.30	12.27	0.36	0.00	0.36
Basophils, donor3	12243-129H2	105.54	7.20	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	25.01	1.08	0.65	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.94	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	222.38	21.52	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	112.98	8.79	0.00	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	70.70	4.37	0.00	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	80.60	5.07	0.00	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	112.29	16.73	2.16	0.36	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	117.79	21.85	1.24	0.41	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	232.21	0.23	0.00	0.00	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	188.99	17.27	1.28	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	175.81	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	63.12	6.20	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	64.77	2.23	0.00	0.00	0.37
CD14+ Monocytes, donor3	11381-118B4	49.62	2.63	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	40.48	53.78	2.26	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	46.25	42.46	4.55	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	34.85	55.23	1.64	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	86.87	8.82	0.29	0.29	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	74.23	7.54	0.30	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	87.65	5.69	0.00	0.00	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	92.07	5.36	0.00	0.00	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	90.81	5.24	0.00	0.83	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	138.84	6.45	0.25	0.00	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	102.21	2.94	0.00	0.39	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	103.98	7.66	0.00	0.18	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	185.86	8.49	0.22	0.44	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	159.44	5.15	0.23	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	143.62	13.73	0.00	0.53	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	146.44	7.77	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	89.70	4.46	0.30	0.30	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	89.20	6.19	0.40	0.20	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	158.44	9.58	0.42	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	146.19	3.89	0.00	0.46	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	134.82	8.14	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	127.45	5.24	0.00	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	103.56	3.77	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	97.35	8.03	0.35	0.35	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	95.53	6.31	0.42	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	104.53	2.39	0.18	0.18	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	87.71	2.82	0.35	0.35	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	92.13	3.07	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	109.51	4.01	0.00	0.17	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	98.49	8.18	0.37	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	210.59	14.87	0.65	0.86	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	129.81	2.46	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	124.48	8.81	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	155.67	3.71	0.23	0.46	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	46.64	20.49	0.87	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	49.43	12.94	0.69	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	56.10	18.63	0.65	0.87	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	72.41	17.75	0.62	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	65.84	13.80	0.70	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	82.05	20.07	2.23	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	33.17	21.43	0.51	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	32.06	17.13	1.10	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	42.74	17.48	0.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	77.23	20.32	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	89.49	27.80	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	76.63	23.82	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	91.68	30.92	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	83.63	28.41	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	70.90	27.38	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	75.30	22.75	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	83.05	30.32	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	105.20	9.86	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	83.42	10.16	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	91.37	11.11	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	215.36	10.51	0.40	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	168.98	6.39	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	90.36	9.04	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	207.31	4.49	0.00	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	191.64	15.03	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	233.15	17.81	0.45	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	148.89	19.64	0.36	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	95.53	8.57	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	95.46	13.11	0.61	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	55.64	16.08	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	58.40	15.05	0.67	0.22	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	49.16	13.22	0.57	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	146.02	29.39	0.47	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	134.85	21.77	0.70	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	92.29	32.96	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	64.89	14.16	0.14	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	35.08	10.68	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	31.27	9.99	0.48	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	91.00	12.55	0.45	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	73.02	18.87	0.70	0.35	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	112.20	17.60	0.44	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	61.14	14.76	0.42	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	41.35	11.22	0.21	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	37.09	6.01	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	153.37	23.93	0.82	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	177.40	35.91	1.07	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	132.70	23.31	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	74.36	18.17	0.93	0.37	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	49.61	14.30	0.00	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	49.18	13.24	0.42	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	114.77	15.67	0.00	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	126.08	23.40	0.43	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	159.51	30.07	0.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	99.47	33.65	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	86.78	18.46	1.85	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	89.33	26.52	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	108.00	18.28	1.11	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	113.86	19.63	0.98	0.74	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	124.74	30.80	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	80.22	36.53	0.72	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	95.56	37.39	1.38	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	135.54	13.75	0.00	0.65	0.98
CD8+ T Cells, donor2	11307-117C2	88.23	8.26	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	108.32	12.12	0.00	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	73.86	9.86	0.69	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	75.49	6.23	0.48	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	80.44	11.49	0.55	0.27	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	107.48	12.61	0.90	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	68.88	7.20	0.72	0.00	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	65.03	7.96	0.23	0.45	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	84.31	12.39	0.22	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	77.12	11.05	0.26	0.79	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	77.39	6.57	0.47	0.70	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	90.26	10.57	0.30	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	85.99	8.42	0.58	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	84.46	8.26	0.53	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	71.79	4.38	0.00	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	71.05	5.47	0.00	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	63.40	7.46	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	68.79	6.84	0.72	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	64.45	6.62	0.58	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	66.00	5.19	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	106.16	15.53	0.32	0.95	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	94.42	9.53	0.31	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	104.83	10.90	0.32	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	98.29	5.74	0.38	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	74.88	4.34	0.39	1.18	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	65.81	3.03	0.76	0.00	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	94.75	5.62	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	118.20	4.90	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	107.19	6.01	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	173.64	14.62	5.48	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	262.86	18.78	3.46	0.49	0.99
Cardiac Myocyte, donor3	11686-122I3	655.07	41.99	3.37	1.05	0.74
Chondrocyte - de diff, donor1	11261-116G1	278.37	20.11	2.77	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	123.32	25.23	3.20	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	129.82	30.49	3.41	0.57	0.46
Chondrocyte - re diff, donor2	11339-117F7	562.22	64.46	9.85	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	154.89	24.67	2.83	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	317.08	45.44	2.98	0.69	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	219.96	30.35	1.71	0.43	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	221.24	26.90	1.95	0.35	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	142.78	48.88	3.39	0.92	0.55
Corneal Epithelial Cells, donor1	11526-119I5	11.64	1.76	0.44	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	26.16	4.55	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	30.68	3.32	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	54.81	23.44	1.65	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	53.94	23.97	1.26	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	37.96	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	34.34	16.63	0.54	0.54	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	132.22	16.40	0.68	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	139.06	13.06	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	180.03	13.07	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	164.10	17.84	1.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	121.46	7.04	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	182.97	12.73	1.13	0.00	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	110.88	12.19	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	107.62	13.09	0.87	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	153.87	9.18	0.47	0.47	0.94
Endothelial Cells - Artery, donor3	11413-118E9	151.29	12.45	0.70	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	177.54	30.81	2.22	0.44	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	205.08	34.38	2.43	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	234.26	28.75	3.38	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	139.95	9.51	0.30	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	170.78	17.70	1.56	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	61.39	9.64	0.57	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	342.10	12.40	0.80	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	135.75	7.86	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	411.88	36.28	4.72	0.50	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	160.56	13.69	0.87	0.00	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	183.68	11.36	0.61	0.49	0.37
Endothelial Cells - Vein, donor1	11267-116G7	106.93	12.51	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	151.57	13.97	0.70	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	159.52	11.46	0.94	0.31	0.31
Eosinophils, donor1	12244-129H3	106.73	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	465.37	11.55	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	413.75	7.13	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	27.36	2.44	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	146.42	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	230.30	21.35	1.23	0.41	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	97.66	13.03	0.66	0.22	2.74
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	158.17	13.65	1.41	0.33	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	375.48	32.38	3.52	0.97	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	472.87	42.17	4.78	1.64	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	220.11	24.89	2.21	0.32	1.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	270.08	20.82	2.11	0.00	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	230.21	19.93	2.66	0.66	1.66
Fibroblast - Cardiac, donor1	11268-116G8	213.20	25.40	1.81	0.91	0.91
Fibroblast - Cardiac, donor2	11345-117G4	171.30	12.13	0.00	0.76	1.52
Fibroblast - Cardiac, donor3	11417-118F4	128.38	11.67	0.32	0.32	0.16
Fibroblast - Cardiac, donor4	11452-119A3	625.31	29.70	3.03	0.30	0.61
Fibroblast - Cardiac, donor5	11456-119A7	286.17	16.75	1.40	0.89	0.76
Fibroblast - Cardiac, donor6	11460-119B2	384.90	16.83	1.21	0.91	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	251.50	17.69	2.28	1.34	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	186.81	31.49	1.29	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	256.34	19.04	0.00	1.46	5.86
Fibroblast - Conjunctival, donor1	11531-120A1	52.12	2.54	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	228.63	31.21	3.56	0.85	0.51
Fibroblast - Dermal, donor1	11269-116G9	111.99	10.33	0.23	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	178.29	9.91	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	134.91	8.70	0.60	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	251.75	9.72	1.24	0.11	0.90
Fibroblast - Dermal, donor5	11454-119A5	251.74	8.02	0.52	0.35	1.22
Fibroblast - Dermal, donor6	11458-119A9	334.10	11.86	1.30	0.32	0.65
Fibroblast - Gingival, donor1	11237-116D4	300.48	30.19	3.54	0.00	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	260.43	27.25	2.88	0.79	0.26
Fibroblast - Gingival, donor2	11318-117D4	274.24	17.13	2.37	0.53	0.53
Fibroblast - Gingival, donor3	11394-118C8	153.35	22.82	2.32	0.10	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	192.20	37.40	5.19	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	122.46	16.21	2.11	0.00	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	246.32	15.75	2.18	0.00	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	220.69	13.79	1.22	0.14	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	167.26	6.70	1.06	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	257.10	19.45	2.19	0.29	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	311.29	30.00	3.55	0.68	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	308.24	18.10	1.97	0.22	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	168.46	21.86	1.61	0.15	0.59
Fibroblast - Lung, donor1	11270-116H1	58.45	6.80	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	280.52	11.94	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	184.87	5.06	1.06	0.00	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	118.29	3.33	2.50	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	99.30	2.80	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	11.20	1.12	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	209.89	14.21	2.44	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	43.94	11.98	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	184.64	23.83	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	441.68	20.95	1.75	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	338.86	12.59	1.06	0.15	2.43
Fibroblast - Periodontal Ligament, donor3	11395-118C9	391.97	22.03	1.22	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	190.81	8.01	1.53	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	216.26	19.44	1.35	0.00	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	117.60	18.79	1.51	0.23	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	551.89	28.30	3.09	0.55	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	150.16	15.85	0.81	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	40.76	3.34	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	155.77	18.58	1.58	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	385.78	24.81	1.79	0.99	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	230.19	24.87	2.13	0.00	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	306.66	23.45	2.76	0.20	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	283.71	19.25	3.91	0.60	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	361.10	24.07	2.27	1.08	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	352.53	42.26	5.57	0.25	0.51
Fibroblast - skin normal, donor1	11553-120C5	265.31	28.06	2.30	0.49	1.31
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	373.75	28.87	3.41	1.40	0.60
Fibroblast - skin normal, donor2	11561-120D4	414.11	23.31	2.41	1.21	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	395.93	42.62	4.84	0.91	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	280.52	41.42	3.40	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	282.07	32.99	5.13	1.03	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	286.72	24.30	3.61	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	423.42	18.64	2.66	0.64	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	398.76	18.39	2.87	0.84	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	237.58	28.54	1.25	0.00	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	7312.73	376.72	44.32	0.00	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	79.31	11.33	0.00	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	193.81	8.49	1.39	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	210.01	8.33	1.04	0.26	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	205.94	9.96	1.02	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	160.00	17.61	0.00	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	238.00	22.33	0.64	3.19	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	288.69	33.09	0.29	7.13	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	197.44	17.65	0.00	0.83	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	159.37	22.15	1.37	1.60	2.74
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	192.78	22.98	0.40	3.17	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	188.21	14.01	0.53	1.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	121.98	18.26	1.30	0.65	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	255.16	26.09	1.77	3.98	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	514.98	44.09	0.42	6.22	1.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	374.97	35.46	1.11	3.08	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	376.88	33.04	1.61	5.91	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	466.46	25.27	1.36	1.73	2.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	463.31	29.07	1.25	3.32	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	457.43	23.58	0.41	2.03	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	322.64	38.33	1.83	1.83	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	323.50	29.52	1.49	1.74	1.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	311.91	19.67	0.87	1.97	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	306.41	41.37	1.77	2.36	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	364.33	36.56	1.59	2.38	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	297.15	25.47	2.23	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	336.32	47.79	3.02	2.42	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	456.34	50.55	1.87	2.54	1.70
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	577.96	48.59	1.60	2.57	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	499.89	60.77	3.02	2.19	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	496.96	54.31	3.07	3.59	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	393.71	44.26	2.10	2.77	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	531.21	55.33	2.83	2.66	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	520.66	52.47	1.84	3.27	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	370.11	61.07	2.27	1.24	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	400.30	47.27	2.31	2.08	2.08
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	372.22	41.86	1.50	2.33	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	299.34	42.76	1.32	1.54	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	448.18	48.21	2.09	1.48	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	341.53	45.87	1.46	2.43	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	350.54	46.82	1.60	1.60	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	326.05	38.66	1.99	1.99	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	317.78	39.07	2.06	0.63	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	377.68	42.57	2.74	3.04	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	405.19	42.23	1.46	2.82	1.88
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	319.01	42.15	1.76	2.63	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	356.30	42.92	1.12	3.09	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	318.13	25.46	2.04	1.30	1.67
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	373.83	28.61	1.34	2.41	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	389.70	31.06	1.53	1.53	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	367.11	29.53	1.81	1.68	1.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	335.32	42.83	1.36	0.81	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	379.21	45.53	0.92	0.55	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	374.81	40.79	1.10	1.75	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	318.35	47.60	2.98	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	410.38	47.88	2.11	0.53	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	363.16	39.75	2.22	1.21	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	385.05	62.78	2.03	2.80	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	777.13	49.57	1.59	18.51	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	427.25	38.83	0.92	7.86	1.69
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	514.32	49.10	1.43	10.43	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	557.02	51.32	1.56	4.38	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	569.91	56.51	3.11	6.50	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	426.15	26.75	0.46	4.61	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	487.54	27.22	4.95	4.95	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	534.57	44.10	2.32	5.42	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	681.90	59.37	1.60	4.81	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	366.89	34.78	0.00	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	499.29	41.99	0.65	4.56	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	579.82	47.77	1.65	4.12	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	353.22	43.32	0.00	10.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	497.49	46.14	0.84	3.08	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	505.95	46.74	0.33	3.92	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	418.58	18.45	0.84	2.52	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	580.16	49.30	1.59	3.50	2.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	589.99	40.08	0.68	4.42	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	634.80	29.23	0.00	4.18	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	626.53	42.95	1.15	5.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	465.58	32.56	1.18	3.26	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	542.13	52.52	3.39	10.16	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	671.02	81.60	2.49	4.97	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	506.51	62.36	1.15	3.45	2.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	500.51	52.68	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	508.19	66.89	2.31	3.08	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	564.91	55.74	1.30	5.54	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	494.94	54.18	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	661.50	70.12	2.31	2.70	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	604.23	72.23	0.68	5.48	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	469.62	34.79	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	553.01	58.51	3.77	3.30	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	525.64	66.99	1.21	2.41	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	585.49	62.57	2.54	2.54	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	539.63	63.81	2.39	3.59	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	634.95	78.94	2.47	2.96	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	703.54	50.76	2.36	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	540.27	76.43	0.58	5.83	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	697.38	53.10	3.07	3.51	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	455.21	56.80	4.24	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	376.06	66.26	2.98	5.37	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	493.01	83.46	3.40	3.88	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	144.95	12.55	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	128.90	10.40	1.25	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	130.44	10.12	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	213.45	21.25	1.59	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	131.17	21.30	0.84	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	413.23	30.52	4.53	1.04	1.86
Hep-2 cells mock treated, biol_rep2	11899-125E9	416.10	34.60	4.56	1.35	2.36
Hep-2 cells mock treated, biol_rep3	11900-125F1	376.97	27.30	2.73	0.68	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	427.40	34.54	3.94	0.33	2.40
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	399.52	29.01	3.01	1.29	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	365.98	25.40	4.31	1.72	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	411.47	27.90	2.49	1.37	1.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	396.11	28.48	2.74	0.69	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	360.10	26.27	2.24	0.96	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	70.51	4.48	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	18.61	2.16	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	264.38	13.22	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	160.84	10.23	0.71	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	61.03	5.09	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	278.17	24.65	2.45	0.70	0.52
Hepatocyte, donor1	11523-119I2	176.75	38.74	8.47	0.00	0.00
Hepatocyte, donor2	11603-120I1	200.38	28.01	1.08	2.15	1.08
Hepatocyte, donor3	11684-122I1	130.68	33.74	2.45	1.84	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	87.46	9.79	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	231.76	48.59	1.05	1.57	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	280.59	20.99	2.06	0.27	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	73.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	63.68	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	80.09	7.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	130.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	53.82	12.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	86.84	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	84.47	4.87	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	61.69	6.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	58.09	14.52	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	74.11	5.29	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	74.28	7.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	98.26	3.78	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	86.61	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	74.29	7.11	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	37.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	74.97	4.89	0.81	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	92.78	5.46	1.26	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	82.78	0.80	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	73.86	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	94.88	4.72	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	95.23	2.72	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	53.81	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	58.44	5.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	54.84	0.00	0.64	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	58.33	5.47	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	57.84	2.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	75.31	2.78	0.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	3.51	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	57.72	4.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	12.97	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	56.68	2.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	36.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	42.67	6.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	49.88	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	38.66	1.84	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	43.35	5.29	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	205.96	12.73	1.22	0.41	0.41
Keratinocyte - epidermal, donor2	11349-117G8	83.16	2.93	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	211.65	10.41	0.85	0.57	0.47
Keratinocyte - oral, donor1	11251-116E9	186.96	31.56	2.27	0.57	0.57
Keratocytes, donor1	11527-119I6	76.33	7.56	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	48.04	2.34	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	92.28	19.56	1.19	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	59.34	17.58	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	171.52	16.18	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	214.17	31.02	2.42	0.46	0.12
Lens Epithelial Cells, donor3	11690-122I7	302.43	51.87	4.14	1.51	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	166.36	25.02	1.90	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	93.21	12.00	0.28	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	163.24	18.57	1.42	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	107.01	18.82	1.61	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	80.05	11.66	0.95	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	116.01	13.15	1.51	0.54	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	111.22	16.42	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	63.71	8.60	0.76	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	105.28	13.93	0.70	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	103.23	9.89	0.79	0.40	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	95.39	10.28	1.74	0.58	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	64.06	10.00	0.74	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	95.47	17.07	2.09	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	88.97	12.40	1.19	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	91.20	14.42	1.65	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	114.56	17.55	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	61.41	8.42	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	102.11	15.74	1.28	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	105.64	11.19	0.99	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	58.28	8.79	1.46	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	74.43	10.46	1.00	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	112.51	14.06	0.48	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	84.29	13.46	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	132.76	15.14	0.76	0.61	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	105.76	14.52	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	86.06	9.63	0.63	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	101.20	13.53	0.90	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	117.63	11.01	2.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	90.31	9.78	0.94	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	89.17	12.30	1.27	0.53	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	113.39	7.27	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	88.65	5.62	1.32	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	84.62	12.27	0.87	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	145.49	18.88	1.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	90.93	8.89	0.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	77.13	8.66	0.27	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	117.40	14.15	0.64	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	107.73	9.13	0.61	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	135.63	14.56	1.12	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	117.69	11.73	1.07	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	63.51	5.33	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	55.55	9.96	0.93	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	119.97	12.53	1.07	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	87.55	5.88	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	61.68	11.77	0.94	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	181.05	19.06	2.48	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	43.29	5.63	0.77	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	80.26	10.74	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	237.93	24.93	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	138.85	16.11	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	118.76	15.59	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	169.25	19.46	2.12	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	125.89	13.36	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	111.14	19.61	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	163.34	12.37	0.52	0.00	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	136.79	11.89	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	191.81	24.43	1.13	0.68	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	214.63	22.10	0.87	1.16	2.62
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	201.23	17.56	2.25	1.35	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	225.72	26.69	1.22	0.81	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	163.30	16.95	1.54	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	172.19	20.11	0.35	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	141.92	11.33	0.00	0.67	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	181.34	18.85	1.53	1.02	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	191.83	22.95	0.80	1.07	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	214.26	25.13	1.32	1.13	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	182.84	12.88	0.61	3.07	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	184.29	19.57	2.45	2.45	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	225.53	22.91	0.42	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	226.45	20.46	0.84	1.12	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	159.70	12.36	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	226.44	19.45	1.74	0.58	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	203.87	17.04	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	195.30	16.60	2.21	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	221.28	19.80	1.06	0.71	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	184.02	21.76	0.74	2.21	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	187.66	17.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	193.03	24.56	0.77	1.92	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	195.32	23.21	1.13	0.00	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	140.30	18.87	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	176.69	21.24	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	185.28	25.85	0.72	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	180.00	18.67	0.75	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	202.52	20.81	1.86	0.00	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	186.94	13.78	1.72	0.43	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	174.68	30.83	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	188.58	21.99	1.67	1.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	159.88	21.12	3.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	131.53	18.49	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	181.14	14.78	0.69	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	177.66	13.96	3.22	0.54	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	124.57	10.10	0.67	0.67	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	174.46	17.41	1.11	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	287.24	30.24	1.16	0.00	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	116.35	11.64	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	200.88	19.21	0.40	0.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	154.82	13.81	0.73	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	173.23	17.63	2.30	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	182.51	19.73	1.97	1.97	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	169.37	13.17	1.88	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	163.42	22.63	0.50	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	198.73	21.63	0.90	0.45	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	185.88	13.77	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	198.62	21.82	0.89	0.89	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	185.35	24.24	1.17	1.56	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	176.81	23.09	2.64	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	161.39	24.91	1.56	1.56	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	200.84	19.69	0.44	1.31	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	204.63	19.01	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	186.81	19.43	1.32	0.44	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	200.19	22.37	1.54	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	181.27	24.31	0.51	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	181.19	18.74	2.40	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	208.71	22.26	1.99	0.40	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	201.73	13.98	1.22	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	151.48	7.61	0.69	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	207.48	19.76	0.76	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	213.80	23.76	0.00	1.03	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	142.09	16.33	0.60	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	215.81	21.87	0.63	0.32	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	190.31	14.39	0.53	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	177.57	15.52	0.00	1.72	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	209.81	27.77	0.51	1.54	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	218.57	22.64	0.71	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	196.35	17.02	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	218.83	26.63	1.66	0.83	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	241.96	21.93	2.35	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	184.97	13.78	0.00	1.67	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	197.47	30.20	1.86	1.39	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	187.33	21.41	0.00	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	192.47	9.09	0.00	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	252.16	23.84	0.40	1.62	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	229.44	11.01	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	194.71	9.78	0.00	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	264.99	18.24	0.00	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	230.84	9.20	0.77	0.77	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	186.04	17.51	1.09	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	220.05	18.71	0.89	1.34	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	308.83	28.34	2.60	1.04	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	234.74	17.24	1.33	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	278.53	12.47	2.08	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	40.34	36.47	3.42	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	71.20	27.16	1.84	0.37	0.18
Macrophage - monocyte derived, donor3	11389-118C3	40.24	18.61	1.84	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	235.24	10.09	1.06	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	335.44	23.61	2.38	0.63	0.63
Mallassez-derived cells, donor3	11930-125I4	277.42	14.73	1.39	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	339.58	26.11	1.79	0.30	0.40
Mammary Epithelial Cell, donor2	11350-117G9	290.71	14.19	1.45	0.87	0.29
Mammary Epithelial Cell, donor3	11422-118F9	91.54	5.24	0.75	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	1311.81	29.15	0.68	0.00	0.68
Mast cell, donor1	11563-120D6	221.80	21.84	1.08	0.32	0.22
Mast cell, donor2	11565-120D8	357.50	22.88	0.59	1.49	0.59
Mast cell, donor3	11566-120D9	390.14	26.11	1.80	1.13	1.13
Mast cell, donor4	11567-120E1	306.36	27.13	1.06	2.13	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	238.86	34.71	2.00	0.22	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	370.64	8.76	2.33	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	164.05	25.35	1.61	0.34	0.00
Mast cell, expanded, donor8	11941-126A6	118.83	12.89	1.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	197.20	18.61	1.59	0.20	0.40
Melanocyte - dark, donor2	11582-120F7	286.56	22.50	2.42	0.69	1.04
Melanocyte - dark, donor3	11663-122F7	228.41	32.24	2.32	0.94	0.29
Melanocyte - light, donor1	11274-116H5	99.44	15.98	0.24	0.00	0.24
Melanocyte - light, donor2	11351-117H1	45.73	8.87	2.05	0.00	0.00
Melanocyte - light, donor3	11423-118G1	70.25	4.34	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	183.89	16.66	2.08	0.10	1.04
Melanocyte, donor2 (MC+2)	12739-135I3	162.98	12.10	1.34	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	136.61	13.93	1.34	0.54	0.27
Meningeal Cells, donor1	11493-119E8	340.79	10.92	1.61	0.37	0.00
Meningeal Cells, donor2	11573-120E7	207.75	16.29	1.32	0.88	0.00
Meningeal Cells, donor3	11654-122E7	519.90	26.57	2.93	0.65	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	378.69	20.25	3.42	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	259.13	25.56	3.12	0.10	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	227.48	9.33	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	372.92	28.17	2.33	1.06	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	228.70	17.09	1.51	0.50	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	123.94	4.61	1.10	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	89.86	5.11	0.00	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	75.91	2.86	0.20	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	313.86	21.33	2.08	0.00	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	62.45	5.20	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	444.59	47.10	4.47	1.18	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	207.42	5.64	0.59	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	81.74	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	156.90	6.40	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	427.11	20.91	1.06	1.06	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	422.18	46.28	2.81	0.63	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	288.10	15.24	0.73	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	194.37	29.17	2.39	0.53	0.53
Mesothelial Cells, donor2	12156-128G5	265.75	28.03	0.50	1.00	0.50
Mesothelial Cells, donor3	11402-118D7	136.07	15.03	1.08	0.36	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	36.46	4.05	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	63.05	17.98	0.99	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	64.19	12.96	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	50.52	17.67	1.86	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	47.92	10.37	1.04	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	53.31	18.52	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	59.12	9.31	0.47	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	51.41	14.43	0.81	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	56.62	8.32	1.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	45.13	7.08	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	71.43	20.14	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	3.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	49.02	14.43	0.42	0.21	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	20.26	3.68	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	38.75	7.75	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	59.46	15.05	0.75	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	55.38	8.79	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.93	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	62.17	11.28	1.38	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	57.42	9.68	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	59.72	9.38	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	73.37	17.81	1.07	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	52.24	5.33	0.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	57.60	7.67	0.88	0.22	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	35.49	2.53	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	72.02	7.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	64.99	4.71	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	56.71	5.29	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	76.84	5.60	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	26.05	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	64.07	7.51	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	92.40	4.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	21.77	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	108.09	7.19	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	25.05	2.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	71.45	9.91	0.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	28.01	2.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	16.69	1.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	70.98	10.10	0.84	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	23.28	4.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.32	1.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	34.99	6.64	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	54.68	7.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	41.56	9.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	50.08	8.54	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	31.09	6.77	0.97	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	41.72	13.73	1.30	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	42.90	5.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.16	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	27.22	6.41	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	34.12	9.58	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	22.74	5.09	0.85	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	39.81	15.61	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	41.35	9.95	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	21.99	2.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	42.33	14.49	1.14	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	44.24	11.31	0.74	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	1.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	39.11	11.47	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	47.00	12.69	1.15	0.86	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	45.75	21.43	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	22.33	11.91	0.30	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	40.99	26.73	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	39.43	21.69	1.64	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	36.82	14.73	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	29.65	30.84	1.98	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.94	25.15	5.59	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	28.54	25.16	3.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	26.37	17.05	1.07	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	48.63	25.90	1.58	0.57	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	31.68	12.52	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	28.21	16.86	0.37	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	43.56	21.78	0.00	1.56	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	88.72	21.91	1.07	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	15.46	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	32.32	15.15	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	43.85	14.76	2.11	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	113.04	25.88	2.72	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	108.09	9.54	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	97.18	16.20	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	64.95	10.57	1.51	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	131.33	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	290.36	13.05	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	71.29	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	386.71	26.71	3.88	0.65	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	166.19	22.99	1.57	0.52	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	95.45	2.67	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	63.44	1.25	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	256.31	9.32	0.95	0.19	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	237.78	6.38	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	40.80	2.72	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1067.67	34.92	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	63.62	5.02	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	117.15	5.58	0.23	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	71.34	5.67	0.81	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	126.14	6.52	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	3229.07	144.75	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	77.43	6.95	0.00	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	133.98	3.25	0.81	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	88.18	3.63	1.13	0.23	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	74.30	6.37	0.33	0.33	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	146.53	14.03	1.64	0.00	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	70.02	12.73	0.53	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	48.62	4.20	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	288.47	18.05	0.33	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	72.20	5.37	0.16	0.00	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	159.98	10.94	0.88	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	69.62	7.03	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	73.09	4.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	84.19	4.50	0.64	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	359.03	17.59	1.72	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1428.57	85.97	10.11	2.53	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	112.06	8.02	0.22	0.45	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	85.95	4.66	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	96.13	8.54	0.24	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	106.88	6.87	0.43	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	3936.10	234.72	0.00	0.00	36.11
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	84.64	4.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	109.56	6.76	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	81.74	9.13	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	54.79	1.86	0.00	0.00	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	158.16	8.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	69.09	4.56	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	41.84	4.36	0.44	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	142.47	11.76	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	90.84	2.65	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	71.14	6.65	0.66	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	113.10	5.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	75.03	1.91	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	136.10	12.40	0.30	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	158.70	16.58	1.11	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	61.67	8.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1348.92	71.53	25.55	0.00	20.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	100.60	6.71	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	72.39	4.09	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	51.75	4.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	87.03	12.66	3.16	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	317.42	23.81	1.13	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1653.93	116.33	5.06	0.00	10.12
Myoblast, donor1	11241-116D8	348.09	24.85	2.73	0.12	0.75
Myoblast, donor2	11322-117D8	244.53	21.86	0.96	0.00	1.15
Myoblast, donor3	11398-118D3	324.22	19.51	2.02	0.34	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	37.21	6.71	0.00	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	133.15	10.15	0.00	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	84.74	7.84	0.00	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	101.78	7.18	0.18	0.37	0.18
Neural stem cells, donor1	11275-116H6	308.50	41.01	3.27	1.45	1.09
Neural stem cells, donor2	11352-117H2	356.24	15.41	1.93	0.00	0.00
Neurons, donor1	11494-119E9	298.13	17.07	0.00	0.00	0.00
Neurons, donor2	11574-120E8	281.37	27.96	1.54	0.22	0.00
Neurons, donor3	11655-122E8	235.14	16.44	1.64	0.00	0.82
Neutrophils, donor1	11233-116C9	125.28	4.64	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	84.07	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	252.89	9.77	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	232.13	50.58	3.92	0.36	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	128.94	16.61	1.30	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	159.84	11.63	1.00	0.40	0.60
Olfactory epithelial cells, donor1	11933-125I7	180.05	28.36	2.48	0.28	1.10
Olfactory epithelial cells, donor2	11934-125I8	242.30	31.55	2.61	0.29	2.32
Olfactory epithelial cells, donor3	11935-125I9	176.95	25.54	2.27	0.23	1.02
Olfactory epithelial cells, donor4	11936-126A1	183.40	28.05	1.27	0.29	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	355.68	23.47	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	193.34	22.55	2.98	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	86.88	20.58	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	63.93	14.90	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	185.86	17.98	2.15	0.59	0.20
Osteoblast, donor2	11354-117H4	491.62	15.45	4.92	0.00	0.70
Osteoblast, donor3	11426-118G4	199.24	17.77	0.71	0.89	0.53
Pancreatic stromal cells, donor1	11249-116E7	260.88	29.99	2.11	0.34	0.76
Pericytes, donor1	11491-119E6	22.14	2.67	0.89	0.00	0.00
Pericytes, donor2	11571-120E5	23.77	2.26	0.23	0.45	0.00
Pericytes, donor3	11652-122E5	142.62	10.38	0.61	0.20	0.20
Perineurial Cells, donor1	11499-119F5	408.80	29.50	2.37	0.57	0.34
Perineurial Cells, donor2	11579-120F4	464.38	29.44	2.48	1.01	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	91.80	17.53	1.59	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	65.62	8.57	0.24	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	47.88	8.54	0.13	0.26	0.13
Placental Epithelial Cells, donor1	11278-116H9	204.49	10.76	0.96	1.20	0.48
Placental Epithelial Cells, donor2	11355-117H5	233.97	11.09	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	173.55	9.82	0.20	0.98	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	143.35	12.34	0.63	0.00	2.22
Preadipocyte - breast, donor1	11467-119B9	348.16	28.51	3.75	0.38	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	518.72	40.07	4.70	0.91	0.13
Preadipocyte - breast, donor2	11328-117E5	260.50	25.89	2.70	0.23	1.80
Preadipocyte - omental, donor1	11468-119C1	410.25	36.34	5.01	0.21	1.70
Preadipocyte - omental, donor2	11329-117E6	420.76	25.32	0.87	0.00	1.31
Preadipocyte - omental, donor3	11403-118D8	347.23	21.34	2.01	0.57	0.43
Preadipocyte - perirenal, donor1	11469-119C2	283.47	12.80	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	159.09	15.05	2.15	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	313.60	16.11	1.77	0.00	1.95
Preadipocyte - subcutaneous, donor3	11428-118G6	259.17	20.09	2.38	0.34	0.51
Preadipocyte - visceral, donor1	11280-116I2	419.44	20.96	3.45	0.09	0.47
Preadipocyte - visceral, donor2	11357-117H7	279.33	12.89	2.30	0.00	1.38
Preadipocyte - visceral, donor3	11429-118G7	203.23	8.46	0.84	0.21	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	227.94	42.99	0.30	2.87	0.60
Prostate Epithelial Cells, donor2	11331-117E8	165.88	11.51	0.81	0.41	1.35
Prostate Epithelial Cells, donor3	11404-118D9	76.85	16.53	0.37	0.18	0.49
Prostate Stromal Cells, donor1	11254-116F3	351.16	34.63	2.96	0.46	0.91
Prostate Stromal Cells, donor2	11332-117E9	290.46	24.03	3.59	0.54	0.54
Prostate Stromal Cells, donor3	11405-118E1	138.48	26.17	1.36	0.21	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	22.26	1.09	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	158.45	27.93	1.32	0.42	0.28
Renal Epithelial Cells, donor1	11517-119H5	17.25	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.96	1.42	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	219.78	28.58	1.69	0.64	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.06	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	99.59	4.45	0.67	0.00	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	161.40	14.43	1.33	0.44	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	14.64	3.33	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	39.18	5.06	0.00	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	41.38	4.39	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	10.82	1.39	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	129.11	7.78	0.81	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	45.12	5.48	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	53.42	3.86	0.00	0.19	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	258.76	31.37	3.63	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	96.64	13.08	0.57	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	30.87	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	174.38	32.12	2.26	0.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	207.67	66.55	2.14	1.20	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	144.73	8.04	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	292.80	17.06	2.75	1.10	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	262.18	15.66	1.16	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	272.27	4.68	0.91	0.39	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	160.18	4.17	0.60	0.10	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	271.82	7.81	0.56	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	334.79	8.06	0.99	0.37	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	179.36	5.48	0.70	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	248.24	6.93	0.23	0.69	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	156.08	2.05	0.41	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	197.87	5.60	0.76	0.00	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	223.45	5.73	0.36	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	168.56	3.30	0.43	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	187.05	4.83	0.43	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	185.42	3.54	0.66	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	151.22	1.72	0.38	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	156.79	3.63	0.47	0.09	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	295.58	9.02	0.94	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	154.07	2.79	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	169.86	4.28	0.78	0.10	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	211.77	4.01	1.91	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	163.39	2.67	0.32	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	183.32	4.20	0.28	0.28	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	185.77	4.61	0.68	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	142.40	1.46	0.18	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	148.14	4.91	0.12	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	191.14	4.70	0.27	0.27	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	186.81	4.48	0.00	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	166.07	3.97	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	202.04	5.38	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	166.30	2.70	0.62	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	219.00	5.09	0.44	0.22	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	156.45	3.55	0.00	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	164.06	3.63	0.54	0.27	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	155.65	4.43	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	166.00	3.66	0.77	0.00	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	194.29	5.33	1.20	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	130.58	3.43	0.41	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	196.67	3.94	0.33	0.16	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	146.91	3.07	0.17	0.34	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	186.43	5.62	0.74	0.15	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	158.33	3.47	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	150.57	4.29	0.41	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	173.10	7.14	0.95	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	193.48	4.84	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	164.24	4.80	1.04	0.09	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	177.83	10.13	1.05	0.70	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	130.25	8.76	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	174.65	2.33	0.61	0.12	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	327.78	18.63	1.31	0.58	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	174.62	14.60	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	176.62	5.12	0.30	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	159.24	9.95	0.00	0.23	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	166.24	11.98	1.50	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	239.69	9.80	1.77	1.06	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	156.46	12.38	1.49	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	166.47	14.42	1.20	0.00	0.60
Schwann Cells, donor1	11498-119F4	30.66	1.50	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	129.29	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	235.73	16.87	0.88	0.66	0.44
Sebocyte, donor1	11220-116B5	288.67	16.43	1.10	0.00	1.10
Sebocyte, donor2	11301-117B5	153.03	17.00	1.38	0.46	0.92
Sebocyte, donor3	11378-118B1	114.80	22.88	1.03	0.41	0.21
Sertoli Cells, donor1	11255-116F4	336.29	24.85	1.66	0.00	4.97
Sertoli Cells, donor2	11333-117F1	228.77	28.24	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	190.38	18.74	1.23	0.18	0.18
Skeletal Muscle Cells, donor2	11358-117H8	46.26	2.17	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	126.24	5.85	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	295.02	8.01	0.94	0.16	0.63
Skeletal Muscle Cells, donor5	11455-119A6	266.22	9.51	0.89	0.30	1.04
Skeletal Muscle Cells, donor6	11459-119B1	313.81	9.08	0.77	0.62	1.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	345.00	50.28	4.03	0.13	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	236.15	18.98	1.85	0.00	1.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	284.04	13.59	1.69	0.99	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	302.13	29.91	2.86	0.84	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	65.86	7.96	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	102.10	11.28	0.55	0.69	0.69
Skin - palm, donor1	10286-104F7	45.66	13.43	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	69.20	13.12	1.01	0.58	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	273.99	16.36	4.09	4.91	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	77.90	11.17	1.43	0.13	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	253.97	22.66	1.25	0.42	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	116.60	14.07	0.28	0.00	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	290.74	36.37	2.11	1.90	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	99.16	14.17	0.52	0.97	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	191.63	8.33	2.16	0.00	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	232.56	15.79	2.45	0.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	196.33	13.52	1.18	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	186.74	17.90	1.55	0.44	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	212.25	9.84	2.76	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	174.60	14.68	1.55	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	109.08	22.02	4.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	235.28	14.37	1.73	0.27	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	251.58	31.92	2.66	0.44	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	305.35	26.76	2.56	0.77	2.82
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	294.98	22.47	3.91	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	423.79	20.97	2.07	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	289.43	10.82	0.71	0.14	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	46.36	1.30	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	102.59	19.48	0.61	0.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	157.60	22.73	2.78	0.25	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	250.95	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	138.76	9.06	0.95	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	319.43	22.12	1.62	0.15	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	221.05	15.50	1.72	0.43	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	239.72	15.53	1.26	0.42	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	214.54	15.47	1.24	0.31	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	113.18	16.17	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	164.97	8.67	0.90	0.90	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	43.36	1.37	0.68	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	212.66	32.04	1.65	0.63	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	317.82	29.69	2.01	1.11	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	179.08	18.66	1.14	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	118.35	5.43	0.00	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	410.63	19.60	1.06	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	309.86	19.31	2.53	1.07	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	185.33	18.41	2.25	0.50	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	162.85	26.89	2.54	0.25	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	302.60	25.18	3.62	0.75	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	96.77	11.25	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	355.36	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	233.47	22.79	1.40	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	170.15	15.15	1.51	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	121.91	10.66	0.31	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	55.46	3.83	0.29	0.29	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	454.69	20.83	2.50	0.50	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	162.10	14.95	0.93	0.00	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	218.61	17.56	0.86	0.58	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	159.86	17.85	1.53	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	118.65	9.78	0.75	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	446.20	26.55	2.66	0.00	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	573.87	31.25	1.59	0.84	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	24.76	0.95	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	206.98	15.41	0.98	0.73	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	443.22	17.23	2.21	0.88	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	322.13	18.43	0.88	0.88	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	105.34	10.11	1.17	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	126.14	13.49	2.12	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	209.41	20.46	1.86	0.00	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	139.42	15.81	1.08	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	100.50	7.67	0.28	0.00	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	218.60	13.00	1.58	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	133.58	17.01	2.79	0.25	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	108.61	12.38	0.80	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	104.50	14.21	1.67	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	94.88	13.29	4.13	0.00	0.00
Synoviocyte, donor1	11291-117A4	499.41	46.12	3.20	0.34	1.01
Synoviocyte, donor2	11368-117I9	102.92	31.18	3.35	0.67	1.17
Synoviocyte, donor3	11440-118H9	82.89	18.32	2.01	0.89	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	98.98	4.29	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	36.82	2.32	0.00	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	159.86	19.43	1.22	0.36	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	61.08	5.41	0.39	0.39	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	42.95	4.58	0.00	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	213.82	60.90	3.69	1.60	0.25
Urethra, donor2	10319-105A4	95.32	21.58	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	49.41	5.31	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	36.45	3.61	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	22.00	1.83	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	214.65	23.18	1.78	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	75.63	12.46	0.00	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	82.92	11.44	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	27.38	9.58	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	58.88	19.97	0.69	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	52.87	16.85	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	88.51	10.41	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	88.11	8.26	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	29.21	7.30	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	171.84	24.18	1.48	2.10	0.99
Wilms' tumor cell line:HFWT	10597-108E3	53.68	12.32	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	148.60	12.85	1.96	0.28	0.00
achilles tendon, donor2	10292-104G4	107.46	10.33	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	224.62	11.47	0.00	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	183.65	21.13	1.86	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	171.65	17.09	0.36	0.47	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	182.86	17.42	0.54	0.82	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	132.95	6.75	0.56	0.56	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	126.68	22.21	1.90	0.63	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	221.58	14.16	0.54	0.00	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	195.20	11.46	0.44	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	161.30	21.23	0.82	0.00	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	97.46	11.26	1.16	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	113.53	4.42	0.37	0.18	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	144.32	7.80	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	158.02	16.96	3.02	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	158.45	12.69	1.29	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	127.71	19.29	0.58	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	104.57	13.01	0.93	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	140.65	22.21	1.23	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	66.30	6.45	0.61	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	184.34	25.18	1.28	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	172.88	27.90	1.82	0.30	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	201.47	28.64	1.93	0.48	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	105.13	10.91	0.89	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	179.45	11.01	0.67	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	224.84	11.15	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	165.73	16.20	1.88	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	146.10	8.29	1.31	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	155.58	5.62	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	105.03	27.08	0.47	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	88.11	46.23	4.34	1.24	0.62
adipose, donor1	10184-103D4	649.74	66.26	1.76	2.35	4.10
adipose, donor2	10185-103D5	109.90	15.82	0.81	1.22	1.22
adipose, donor3	10186-103D6	183.25	29.13	2.18	1.36	1.63
adipose, donor4	10187-103D7	524.38	14.73	0.87	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	215.74	14.84	2.68	0.47	0.63
adrenal gland, adult, pool1	10081-102A9	72.75	10.91	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	92.05	10.81	0.00	0.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	115.05	8.93	1.43	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	572.67	51.24	2.78	1.16	1.62
amniotic membrane cells, donor2	12236-129G4	510.20	28.74	1.35	0.68	0.68
amniotic membrane cells, donor3	12237-129G5	517.03	58.92	2.95	2.65	1.77
amygdala - adult, donor10196	10167-103B5	275.10	65.22	4.74	7.11	1.19
amygdala, adult, donor10252	10151-102I7	161.40	65.90	3.85	2.03	1.01
amygdala, newborn, donor10223	10360-105E9	190.11	35.18	4.52	0.97	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	289.80	59.97	2.55	0.76	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	188.19	12.80	0.66	0.22	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	140.96	16.70	0.33	1.00	0.33
aorta, adult, pool1	10052-101G7	114.35	52.37	1.37	1.37	0.59
appendix, adult	10189-103D9	87.33	28.33	1.94	1.16	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	241.10	36.46	1.03	1.03	0.69
artery, adult	10190-103E1	133.15	48.91	4.08	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	357.97	37.38	2.03	0.58	0.72
b cell line:RPMI1788	10427-106D4	235.69	16.21	0.59	0.89	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	533.25	41.34	1.39	0.28	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	191.22	16.77	0.89	0.40	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	94.40	37.66	1.34	0.67	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	73.82	15.66	1.12	0.00	1.12
bladder, adult, pool1	10011-101C2	194.36	67.90	2.61	1.52	0.54
blood, adult, pool1	10053-101G8	22.15	4.43	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	382.79	27.40	3.43	0.00	0.00
bone marrow, adult	10192-103E3	160.61	22.94	3.37	1.35	2.02
brain, adult, donor1	10084-102B3	114.81	30.75	2.05	1.03	0.00
brain, adult, pool1	10012-101C3	208.35	89.64	6.12	3.23	0.67
brain, fetal, pool1	10085-102B4	141.58	16.03	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	161.88	16.85	0.33	0.66	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	351.50	33.95	1.12	0.87	0.25
breast, adult, donor1	10080-102A8	81.44	12.00	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	202.37	23.37	1.91	0.13	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	223.26	34.63	1.55	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	250.02	22.33	1.84	0.00	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	168.01	16.46	0.48	0.00	0.48
carcinoid cell line:NCI-H1770	10703-109H1	499.79	17.87	2.82	0.47	2.35
carcinoid cell line:NCI-H727	10735-110B6	228.93	23.19	1.31	1.31	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	349.85	15.21	1.58	0.95	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	250.47	22.63	2.13	0.53	1.86
caudate nucleus - adult, donor10196	10177-103C6	139.31	64.47	4.61	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	157.45	72.95	4.02	1.67	0.67
caudate nucleus, adult, donor10258	10379-105H1	96.28	57.31	7.64	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	175.06	46.88	2.93	2.93	1.46
cerebellum - adult, donor10196	10173-103C2	241.80	84.48	8.74	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	292.94	53.59	4.70	1.07	0.64
cerebellum, adult, pool1	10083-102B2	120.39	42.08	4.14	2.07	0.34
cerebellum, newborn, donor10223	10357-105E6	169.38	48.16	3.32	0.00	0.00
cerebral meninges, adult	10188-103D8	196.16	63.79	3.28	2.52	0.76
cerebrospinal fluid, donor2	10294-104G6	95.75	5.85	1.46	2.92	1.46
cervical cancer cell line:D98-AH2	10552-107I3	370.81	102.95	9.78	1.15	0.58
cervical cancer cell line:ME-180	10553-107I4	311.55	56.68	3.15	2.15	0.99
cervix, adult, pool1	10013-101C4	363.58	71.50	8.71	1.36	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	263.21	15.05	0.84	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	139.77	5.23	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	804.31	29.45	0.75	1.49	2.11
choriocarcinoma cell line:SCH	10785-110H2	139.23	16.76	0.74	1.36	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	312.60	17.79	0.24	0.95	0.24
chorionic membrane cells, donor1	12238-129G6	1034.26	72.37	3.13	3.70	2.28
chorionic membrane cells, donor2	12239-129G7	736.59	35.89	2.68	0.80	2.39
chorionic membrane cells, donor3	12240-129G8	1401.73	88.47	1.10	4.40	10.44
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	77.75	12.12	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	153.68	9.22	0.38	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	115.31	2.53	0.42	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	235.74	15.66	1.54	0.77	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	249.62	16.45	1.21	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	232.73	13.85	1.02	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	338.33	9.13	0.00	0.00	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	225.44	8.86	0.52	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	383.10	31.32	3.43	0.46	4.80
clear cell carcinoma cell line:TEN	10636-108I6	333.83	96.47	4.68	2.43	0.69
colon carcinoma cell line:CACO-2	10513-107D9	308.06	31.48	0.92	2.20	0.37
colon carcinoma cell line:COLO-320	10420-106C6	536.67	41.05	1.52	0.00	0.38
colon, adult, donor1	10082-102B1	73.78	13.09	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	96.12	44.77	1.65	1.41	0.12
colon, fetal, donor1	10070-101I7	65.51	30.90	0.00	1.85	1.24
common myeloid progenitor CMP, donor1	12130-128D6	36.67	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	298.73	27.20	0.85	1.27	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	229.72	18.26	0.45	0.75	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	246.21	25.95	0.85	0.99	0.00
corpus callosum, adult, pool1	10042-101F6	110.34	98.84	3.43	4.20	0.11
cruciate ligament, donor2	10295-104G7	119.14	19.45	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	76.24	28.89	0.80	0.00	1.61
diencephalon, adult	10193-103E4	94.32	57.84	2.16	2.16	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	212.85	12.40	0.23	0.00	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	343.37	40.77	2.56	0.51	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	193.06	26.96	1.44	1.44	0.72
ductus deferens, adult	10196-103E7	303.99	39.87	1.99	1.00	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	82.09	36.01	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	177.29	44.87	0.74	1.47	2.21
dura mater, adult, donor1	10041-101F5	173.43	65.66	2.97	1.24	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	176.77	9.77	0.00	1.11	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	262.23	18.91	1.43	1.58	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	101.12	14.18	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	92.93	19.37	0.91	0.30	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	102.50	16.05	1.23	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	120.84	13.13	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	153.85	13.41	0.67	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	259.17	30.99	2.36	0.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	180.11	20.91	1.77	0.80	1.61
epidermoid carcinoma cell line:A431	10426-106D3	333.36	15.23	0.67	0.67	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	296.96	47.84	3.08	1.87	0.22
epididymis, adult	10197-103E8	196.75	45.84	3.14	2.72	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	180.25	38.85	5.68	0.71	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	55.05	8.65	0.39	0.39	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	360.91	34.60	1.44	0.92	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	234.34	22.93	1.57	0.30	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	336.65	28.57	2.69	1.01	1.23
esophagus, adult, pool1	10015-101C6	127.63	38.54	2.76	1.06	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	187.23	72.14	6.01	1.63	0.13
eye - muscle inferior rectus, donor1	10272-104E2	55.54	24.15	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	71.54	21.04	0.00	2.10	2.10
eye - muscle medial, donor2	10299-104H2	50.60	19.35	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	63.06	14.90	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	64.13	4.37	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	98.90	49.58	3.31	1.02	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	129.89	14.23	1.15	0.38	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	151.24	5.46	0.47	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	340.49	81.16	6.47	3.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	435.96	39.63	2.10	1.20	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	158.46	24.05	0.73	0.27	0.00
gall bladder, adult	10198-103E9	94.16	37.18	3.14	0.48	0.72
gamma delta positive T cells, donor1	11937-126A2	72.48	20.40	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	61.63	20.54	0.75	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	154.61	19.64	1.06	0.42	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	245.06	43.71	3.09	1.93	0.97
gastric cancer cell line:AZ521	10549-107H9	211.99	26.23	3.44	0.98	0.33
gastric cancer cell line:GSS	10560-108A2	220.57	17.39	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	256.33	14.39	0.23	0.00	1.14
giant cell carcinoma cell line:LU65	10487-107B1	136.54	23.52	1.15	0.34	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	179.99	21.41	1.12	0.70	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	137.43	23.45	1.50	0.25	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	130.46	21.74	0.84	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	137.21	16.99	2.11	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	345.80	34.99	1.66	0.88	0.22
glioma cell line:GI-1	10413-106B8	217.90	11.42	0.59	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	86.74	48.84	1.46	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	167.20	71.52	1.46	1.46	0.73
globus pallidus, adult, donor10258	10367-105F7	45.18	41.08	2.74	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	89.53	25.05	2.66	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	26.92	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	120.21	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	94.08	15.68	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	242.88	14.08	0.32	0.00	1.28
hIPS +CCl2, biol_rep1	14383-156B9	425.60	25.25	2.30	14.23	0.00
hIPS +CCl2, biol_rep2	14384-156C1	393.70	23.32	1.37	8.69	0.91
hIPS +CCl2, biol_rep3	14385-156C2	366.49	28.98	0.64	8.37	0.64
hIPS, biol_rep1	14380-156B6	214.16	15.81	0.00	23.00	0.00
hIPS, biol_rep2	14381-156B7	325.79	19.89	1.37	10.29	0.00
hIPS, biol_rep3	14382-156B8	186.49	43.04	6.62	6.62	1.10
hairy cell leukemia cell line:Mo	10712-109I1	105.17	6.61	0.57	0.29	0.00
heart - mitral valve, adult	10205-103F7	142.31	41.86	4.19	0.90	1.49
heart - pulmonic valve, adult	10206-103F8	77.40	50.46	4.71	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	124.90	40.80	1.67	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	100.40	29.59	1.63	0.82	2.04
heart, adult, diseased, donor1	10051-101G6	109.01	36.20	3.41	0.85	1.28
heart, adult, pool1	10016-101C7	86.24	38.18	1.61	0.46	0.46
heart, fetal, pool1	10046-101G1	257.73	62.63	3.70	2.26	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	254.84	13.58	1.23	0.00	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	400.75	23.78	0.00	1.19	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	273.70	13.37	0.88	0.77	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	293.12	17.24	0.49	1.34	1.34
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	310.94	21.12	0.81	1.01	1.11
hepatoma cell line:Li-7	10484-107A7	247.57	43.82	1.56	1.56	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	143.21	11.56	0.70	0.60	0.40
hippocampus - adult, donor10196	10169-103B7	211.98	39.75	0.95	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	142.67	72.25	5.10	2.65	1.02
hippocampus, adult, donor10258	10374-105G5	168.31	40.83	4.98	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	123.01	23.62	3.17	1.06	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	378.41	53.10	0.00	9.16	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	195.57	22.78	0.39	2.95	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	186.87	31.23	1.02	2.79	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	169.16	12.97	2.26	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	186.17	14.72	0.77	1.03	3.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	212.96	23.16	0.38	1.14	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	167.58	37.08	1.17	2.92	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	165.66	30.59	0.65	2.15	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	121.37	33.78	1.25	3.75	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	245.32	83.59	2.84	4.26	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	167.63	53.84	2.25	3.21	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	222.86	66.66	2.02	4.71	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	206.25	25.82	0.16	2.82	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	226.00	25.06	0.00	4.42	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	395.36	44.51	2.62	6.11	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	218.21	23.10	0.95	1.34	1.91
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	177.48	19.62	0.87	1.74	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	264.37	25.49	1.50	3.00	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	193.48	36.55	1.32	1.13	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	207.35	45.02	1.82	0.91	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	166.64	39.15	1.57	2.82	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	187.31	65.16	3.10	3.59	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	179.99	68.22	3.19	3.19	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	147.97	58.89	1.79	2.09	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	218.55	28.27	0.74	2.96	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	209.40	23.11	1.14	3.42	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	303.78	39.61	1.22	7.35	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	216.88	27.46	2.11	1.41	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	183.71	18.69	0.95	0.32	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	170.68	27.24	1.82	1.51	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	124.11	40.85	1.03	3.62	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	140.80	29.22	1.99	1.99	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	129.29	49.25	1.80	2.82	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	184.07	54.71	1.53	3.07	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	164.32	66.64	3.79	5.30	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	159.63	56.12	3.02	6.05	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	205.76	21.25	0.97	4.59	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	262.05	46.79	0.89	3.12	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	188.78	26.34	0.00	2.44	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	193.46	26.89	0.92	1.83	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	2300.04	266.77	19.52	13.01	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	287.92	36.07	1.99	2.32	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	168.57	39.95	2.74	4.38	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	128.11	36.91	1.81	1.45	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	136.65	37.37	1.78	1.78	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	144.40	50.12	0.00	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	269.90	79.77	3.25	3.93	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	131.46	49.03	2.96	2.42	0.27
immature langerhans cells, donor1	11904-125F5	264.18	18.40	0.73	0.73	0.24
immature langerhans cells, donor2	11905-125F6	177.44	15.84	0.79	0.79	0.79
insula, adult, pool1	10039-101F3	358.85	80.06	6.53	2.56	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	139.81	35.44	1.63	1.30	0.98
kidney, adult, pool1	10017-101C8	176.82	50.86	3.90	1.40	0.50
kidney, fetal, pool1	10045-101F9	142.46	51.35	3.54	1.34	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	270.55	20.88	1.14	0.85	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	331.37	38.57	2.07	0.97	1.11
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	230.48	19.45	0.92	1.47	0.73
left atrium, adult, donor1	10079-102A7	50.67	25.61	1.63	1.09	0.54
left ventricle, adult, donor1	10078-102A6	59.16	23.77	1.01	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	141.73	8.76	0.27	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	123.94	16.53	2.16	0.36	2.87
leiomyoma cell line:15242A	10570-108B3	186.96	18.48	0.54	0.00	1.09
leiomyoma cell line:15425	10571-108B4	179.93	21.12	2.91	0.00	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	304.77	38.10	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	151.61	26.14	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	215.10	7.56	0.12	0.24	0.47
liposarcoma cell line:KMLS-1	10782-110G8	247.12	19.84	1.72	0.62	0.47
liposarcoma cell line:SW 872	10726-110A6	149.37	14.62	0.97	0.49	0.24
liver, adult, pool1	10018-101C9	258.16	38.89	5.02	0.81	0.00
liver, fetal, pool1	10086-102B5	85.60	9.41	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	147.14	47.10	1.90	2.04	0.29
locus coeruleus, adult, donor10252	10165-103B3	212.60	59.43	2.21	1.48	0.74
locus coeruleus, adult, donor10258	10375-105G6	141.63	38.94	3.39	2.54	1.13
locus coeruleus, newborn, donor10223	10362-105F2	257.00	53.00	2.94	2.10	0.84
lung adenocarcinoma cell line:A549	10499-107C4	357.75	51.07	3.88	0.69	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	260.60	19.99	2.07	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	175.18	22.54	0.79	1.05	0.13
lung, adult, pool1	10019-101D1	141.99	42.76	3.31	1.06	0.24
lung, fetal, donor1	10068-101I5	487.48	57.94	6.56	1.71	0.00
lung, right lower lobe, adult, donor1	10075-102A3	57.28	34.82	1.37	0.00	0.92
lymph node, adult, donor1	10077-102A5	57.75	11.83	0.47	0.00	1.42
lymphangiectasia cell line:DS-1	10727-110A7	122.74	5.04	0.66	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	123.46	12.38	0.30	0.91	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	255.70	14.44	4.25	0.85	0.00
mature adipocyte, donor1	12231-129F8	141.63	59.05	5.77	1.78	0.00
mature adipocyte, donor2	12232-129F9	139.04	58.94	3.32	1.25	0.00
mature adipocyte, donor3	12233-129G1	174.48	49.78	4.74	0.71	0.47
mature adipocyte, donor4	12234-129G2	163.46	73.44	8.16	1.84	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	573.97	47.89	1.91	0.95	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	329.38	51.89	5.64	6.77	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	207.81	68.60	2.94	2.21	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	219.52	45.43	6.04	3.49	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	711.38	89.14	5.54	3.41	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	357.58	97.54	7.26	3.54	4.56
medial temporal gyrus, adult, donor10252	10156-103A3	211.16	64.73	3.82	2.12	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	136.76	30.82	15.41	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	4463.97	746.39	71.77	14.35	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	233.31	31.23	1.44	1.08	1.44
medulla oblongata - adult, donor10196	10174-103C3	143.42	43.48	1.95	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	201.40	60.22	2.32	0.62	0.62
medulla oblongata, adult, pool1	10038-101F2	175.17	72.16	4.82	4.08	0.08
medulla oblongata, newborn, donor10223	10361-105F1	112.49	46.52	2.78	1.39	1.04
medulloblastoma cell line:D283 Med	10838-111E1	404.96	17.93	1.77	1.11	3.32
medulloblastoma cell line:ONS-76	10759-110E3	155.78	6.36	0.61	0.49	0.49
melanoma cell line:COLO 679	10514-107E1	198.51	23.00	1.72	1.01	0.43
melanoma cell line:G-361	10465-106H6	306.48	35.83	2.71	1.63	1.09
meningioma cell line:HKBMM	10691-109F7	293.25	49.21	1.63	1.27	3.62
merkel cell carcinoma cell line:MKL-1	10843-111E6	341.01	58.16	4.41	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	283.59	24.11	2.07	0.52	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	397.55	22.09	2.92	0.61	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	256.13	13.82	0.91	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	255.92	16.15	2.48	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	204.67	8.71	1.12	0.42	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	204.31	11.55	1.16	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	187.40	26.37	2.78	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	224.67	18.54	1.89	0.00	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	210.36	14.84	1.50	0.35	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	323.37	12.73	1.46	0.40	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	331.79	15.80	1.22	0.68	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	352.67	10.39	0.85	0.28	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	194.32	22.07	1.65	1.32	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	330.16	20.89	1.80	0.55	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	273.33	14.66	0.70	0.00	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	252.96	17.35	2.65	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	229.33	21.21	1.44	0.36	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	216.93	17.69	1.34	0.62	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	193.57	9.80	1.14	0.23	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	510.60	26.01	2.10	2.10	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	302.91	14.79	2.09	0.45	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	256.81	14.79	1.05	0.44	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	198.07	7.36	0.00	0.74	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	275.86	15.74	2.00	0.00	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	352.39	14.74	3.79	0.00	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	158.46	14.61	3.20	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	188.26	20.46	1.28	0.00	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	168.31	17.01	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	152.50	22.18	1.85	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	184.52	20.24	1.18	0.24	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	181.75	18.28	1.69	0.68	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	152.47	19.65	1.57	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	159.87	22.24	1.85	0.46	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	338.13	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	213.43	27.40	2.88	0.58	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	177.36	22.31	2.01	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	176.18	20.19	0.96	0.24	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	214.87	23.47	2.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	166.49	21.15	3.02	0.34	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	162.52	22.93	0.82	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	183.85	22.34	1.72	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	123.05	21.88	5.47	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	154.95	15.49	5.16	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	183.18	19.49	3.25	0.00	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	177.51	23.28	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	143.93	17.06	0.53	1.07	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	155.38	13.08	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	157.04	23.32	1.94	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	178.39	23.09	2.10	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	177.83	11.92	2.98	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	157.32	28.60	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	162.47	16.01	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	190.08	19.50	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	162.31	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	211.55	8.87	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	301.45	27.59	1.72	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	296.59	17.19	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	299.38	27.94	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	337.50	30.99	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	315.38	17.52	2.04	0.41	3.26
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	361.47	20.66	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	264.70	20.63	1.77	0.00	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	281.47	17.14	1.56	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	315.45	22.72	2.67	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	125.36	27.20	2.37	0.00	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	220.85	20.54	5.14	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	161.08	20.65	1.38	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	96.98	22.27	1.48	0.00	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	78.51	20.19	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	92.23	21.63	2.54	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	78.98	19.34	1.21	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	67.60	17.44	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	74.76	17.74	7.60	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	93.46	15.17	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	112.97	27.11	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	91.43	11.53	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	158.74	25.60	3.37	0.20	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	105.14	14.28	1.30	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	118.16	15.28	3.06	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	194.20	31.72	3.09	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	444.37	24.10	0.94	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	411.45	48.19	2.32	0.93	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	380.35	21.37	0.00	0.00	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	522.79	31.03	2.06	0.41	2.06
mesothelioma cell line:Mero-25	10850-111F4	214.24	24.51	1.13	0.91	1.13
mesothelioma cell line:Mero-41	10851-111F5	301.68	33.00	4.40	0.98	1.47
mesothelioma cell line:Mero-48a	10852-111F6	342.55	15.28	1.11	2.21	1.55
mesothelioma cell line:Mero-82	10853-111F7	201.57	22.86	1.31	0.79	1.31
mesothelioma cell line:Mero-83	10854-111F8	239.84	30.47	2.89	1.19	0.68
mesothelioma cell line:Mero-84	10855-111F9	152.68	18.96	1.52	1.01	1.01
mesothelioma cell line:Mero-95	10856-111G1	231.47	28.16	1.45	0.83	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	175.92	16.23	0.33	1.49	0.00
mesothelioma cell line:NCI-H226	10846-111E9	204.52	17.01	1.45	0.72	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	209.94	28.36	3.59	1.54	0.85
mesothelioma cell line:NCI-H28	10845-111E8	201.54	19.59	1.78	0.51	1.27
mesothelioma cell line:No36	10857-111G2	301.08	16.96	2.94	0.98	0.98
mesothelioma cell line:ONE58	10858-111G3	369.31	24.39	2.98	1.63	1.90
migratory langerhans cells, donor1	11901-125F2	144.71	16.70	1.34	0.96	0.19
migratory langerhans cells, donor2	11902-125F3	85.11	15.14	0.85	0.98	0.24
migratory langerhans cells, donor3	11903-125F4	102.48	17.95	1.62	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	277.83	37.55	1.63	2.29	3.92
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	165.52	13.99	0.00	1.27	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	165.63	24.42	0.69	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	56.33	4.57	0.57	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	181.10	44.35	2.03	0.92	0.00
myeloma cell line:PCM6	10474-106I6	77.29	8.90	0.40	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	267.34	26.38	2.03	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	216.54	16.87	1.37	0.59	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	149.75	14.04	0.78	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	172.08	19.93	1.40	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	353.27	12.14	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	271.47	78.22	2.99	2.53	0.69
neuroblastoma cell line:NB-1	10539-107G8	332.45	32.55	3.93	1.12	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	213.42	10.33	0.42	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	239.09	45.84	2.42	1.30	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	157.52	27.99	0.95	0.71	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	197.50	21.38	1.43	0.00	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	179.52	11.07	0.00	0.40	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	96.00	17.17	1.27	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	246.74	15.44	1.33	0.27	0.53
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	544.40	19.45	0.68	0.68	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	234.55	25.62	1.60	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	226.03	28.53	0.64	0.96	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	271.96	39.41	3.94	0.26	2.36
nucleus accumbens, adult, pool1	10037-101F1	259.19	76.40	6.94	2.16	0.00
occipital cortex - adult, donor10196	10172-103C1	292.57	72.11	2.06	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	184.63	59.31	3.76	1.88	1.07
occipital cortex, newborn, donor10223	10355-105E4	258.40	39.67	4.37	1.46	0.00
occipital lobe, adult, donor1	10076-102A4	206.51	48.54	6.04	1.05	0.52
occipital lobe, fetal, donor1	10073-102A1	195.24	32.61	1.29	0.43	1.72
occipital pole, adult, pool1	10036-101E9	194.27	51.48	4.65	2.76	0.16
olfactory region, adult	10195-103E6	192.77	60.37	3.06	2.48	1.15
optic nerve, donor1	10277-104E7	64.03	50.03	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	237.84	45.11	1.71	0.80	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	226.14	20.88	0.55	1.37	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	223.34	7.11	0.34	0.00	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	92.52	8.89	0.35	0.35	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	182.26	17.64	0.59	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	466.23	37.37	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	290.31	16.96	0.64	0.21	0.00
ovary, adult, pool1	10020-101D2	303.02	77.92	4.28	1.83	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	121.36	7.88	0.55	0.55	0.92
pancreas, adult, donor1	10049-101G4	142.98	15.99	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	655.51	29.91	1.96	1.68	2.52
papillary adenocarcinoma cell line:8505C	10437-106E5	306.98	25.04	1.70	0.68	3.07
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	195.39	59.78	2.15	0.99	0.17
paracentral gyrus, adult, pool1	10035-101E8	277.95	66.72	6.13	2.56	0.18
parietal cortex, adult, donor10258	10373-105G4	217.27	35.23	5.14	5.87	0.00
parietal lobe - adult, donor10196	10171-103B9	256.75	50.79	4.70	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	247.13	58.72	3.42	0.86	0.86
parietal lobe, adult, pool1	10034-101E7	254.58	54.90	5.99	2.82	0.26
parietal lobe, fetal, donor1	10072-101I9	224.03	27.16	0.00	0.97	1.94
parietal lobe, newborn, donor10223	10356-105E5	260.95	30.66	3.74	0.75	0.37
parotid gland, adult	10199-103F1	185.62	31.45	2.47	0.62	1.23
penis, adult	10200-103F2	108.50	53.17	3.76	1.07	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	124.76	5.39	0.74	0.00	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	205.43	31.18	2.04	0.58	0.87
pineal gland - adult, donor10196	10179-103C8	76.76	27.09	2.58	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	166.41	46.19	4.15	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	29.47	25.08	3.14	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	548.40	84.99	7.08	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	747.37	86.52	8.86	5.73	2.08
pituitary gland, adult, donor10258	10378-105G9	258.78	62.99	8.51	1.70	0.85
placenta, adult, pool1	10021-101D3	285.96	76.97	4.19	1.51	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	170.96	8.61	0.13	0.13	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	380.85	24.28	2.33	0.93	1.09
pons, adult, pool1	10033-101E6	293.83	55.26	4.22	2.67	0.26
postcentral gyrus, adult, pool1	10032-101E5	259.78	72.70	5.93	2.70	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	132.19	49.57	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	152.56	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	241.51	19.96	1.02	0.29	0.29
prostate cancer cell line:PC-3	10439-106E7	377.34	32.49	0.91	0.73	1.27
prostate, adult, pool1	10022-101D4	142.93	57.86	5.26	1.63	0.27
putamen, adult, donor10196	10176-103C5	229.45	120.16	7.55	2.12	0.71
putamen, adult, donor10252	10152-102I8	76.47	64.70	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	180.31	34.97	2.19	5.46	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	80.70	52.91	5.32	1.21	0.24
putamen, newborn, donor10223	10365-105F5	353.84	74.22	2.25	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	144.30	14.26	0.00	0.58	0.00
rectum, fetal, donor1	10067-101I4	111.28	37.56	0.00	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	303.58	38.80	1.91	2.12	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	305.69	22.37	2.07	0.00	1.66
retina, adult, pool1	10030-101E3	89.56	59.94	4.27	2.29	0.30
retinoblastoma cell line:Y79	10475-106I7	329.17	73.00	7.79	1.30	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	174.34	18.20	1.97	1.35	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	444.02	25.31	2.53	0.56	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	145.51	25.01	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	138.87	15.05	1.29	0.81	1.13
salivary acinar cells, donor2	11772-123I8	106.71	14.46	1.10	0.41	0.41
salivary acinar cells, donor3	11773-123I9	79.45	8.61	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	199.04	30.31	1.72	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	215.33	17.62	2.78	0.84	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	220.64	19.51	2.23	0.35	0.94
seminal vesicle, adult	10201-103F3	258.72	31.74	3.70	0.53	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	406.41	21.62	2.43	0.24	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	216.91	9.31	0.25	0.25	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	381.34	13.05	0.00	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	154.07	36.40	0.81	1.48	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	173.75	28.85	1.55	1.11	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	178.18	30.19	1.03	2.19	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	145.41	65.26	2.84	2.13	1.42
skeletal muscle, adult, pool1	10023-101D5	155.20	55.65	2.64	2.04	0.12
skeletal muscle, fetal, donor1	10066-101I3	58.29	12.06	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	67.85	27.14	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	164.12	34.72	3.16	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	490.28	37.69	2.67	2.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	325.29	63.67	4.73	3.47	3.47
small cell lung carcinoma cell line:DMS 144	10841-111E4	375.67	28.14	2.51	0.96	2.89
small cell lung carcinoma cell line:LK-2	10541-107H1	320.09	30.99	1.15	0.99	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	599.00	4.18	0.97	0.16	1.45
small cell lung carcinoma cell line:WA-hT	10562-108A4	209.85	23.10	1.09	1.53	0.44
small intestine, adult, pool1	10024-101D6	126.97	48.73	1.31	0.96	0.24
small intestine, fetal, donor1	10064-101I1	124.81	49.38	2.95	1.97	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	212.85	21.54	2.05	2.05	1.03
smooth muscle, adult, pool1	10048-101G3	113.98	66.16	3.36	2.07	1.03
somatostatinoma cell line:QGP-1	10781-110G7	394.26	37.79	0.80	0.80	1.34
spinal cord - adult, donor10196	10181-103D1	125.26	80.52	3.90	3.44	1.38
spinal cord, adult, donor10252	10159-103A6	165.99	71.76	4.73	2.76	0.79
spinal cord, adult, donor10258	10369-105F9	101.00	67.80	10.38	6.23	1.38
spinal cord, fetal, donor1	10056-101H2	126.85	56.10	1.83	1.83	0.61
spinal cord, newborn, donor10223	10359-105E8	193.33	81.28	4.59	1.84	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	217.16	12.10	1.05	0.30	0.75
spleen, adult, pool1	10025-101D7	98.68	28.75	2.64	0.44	0.00
spleen, fetal, pool1	10044-101F8	107.82	27.81	1.59	0.87	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	123.28	14.08	0.41	0.72	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	299.62	33.42	1.33	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	168.09	26.91	2.45	0.00	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	145.82	10.95	0.00	0.78	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	324.39	67.99	2.81	1.01	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	163.93	28.38	0.85	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	334.65	9.31	0.85	0.85	0.42
stomach, fetal, donor1	10062-101H8	175.15	20.29	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	128.18	18.23	1.14	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	162.82	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	159.31	71.24	2.28	1.87	1.25
substantia nigra, adult, donor10258	10371-105G2	138.11	34.66	4.66	5.17	0.00
substantia nigra, newborn, donor10223	10358-105E7	93.27	38.86	2.12	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	421.85	51.81	4.13	2.29	0.92
temporal lobe, adult, pool1	10031-101E4	214.47	53.83	3.98	2.97	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	200.15	24.93	0.00	1.42	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	185.92	27.25	2.64	0.44	0.88
tenocyte, donor1	11763-123H8	218.89	19.20	1.40	0.35	3.49
tenocyte, donor2	11765-123I1	114.83	17.17	2.67	0.00	0.00
tenocyte, donor3	11768-123I4	200.16	18.90	1.85	0.00	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	630.55	35.69	1.02	7.65	1.87
teratocarcinoma cell line:NCR-G1	10798-110I6	135.96	13.41	0.62	0.77	0.31
teratocarcinoma cell line:PA-1	10807-111A6	161.18	10.85	0.31	1.39	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	349.49	16.76	1.27	3.05	1.14
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	238.63	13.61	1.13	5.29	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	345.07	12.43	0.33	1.96	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	312.02	28.66	0.33	5.21	3.91
testis, adult, pool1	10026-101D8	229.46	49.82	3.22	1.18	0.75
testis, adult, pool2	10096-102C6	172.31	17.59	0.90	0.90	0.00
thalamus - adult, donor10196	10168-103B6	130.27	58.51	4.42	6.62	1.10
thalamus, adult, donor10252	10154-103A1	149.88	87.36	1.56	1.88	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	69.28	38.49	10.78	7.70	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	68.02	25.36	2.64	2.31	0.33
thalamus, newborn, donor10223	10366-105F6	224.95	35.67	3.45	2.88	0.00
throat, adult	10209-103G2	120.34	32.96	2.75	0.50	1.00
throat, fetal, donor1	10061-101H7	126.45	38.70	2.74	1.52	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	280.61	14.71	1.59	0.40	1.19
thymus, adult, pool1	10027-101D9	98.12	21.77	0.70	0.40	0.10
thymus, fetal, pool1	10043-101F7	167.29	24.52	1.04	0.83	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	360.59	20.74	1.33	0.53	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	294.19	16.48	2.10	0.14	0.84
thyroid, adult, pool1	10028-101E1	185.51	62.33	3.64	2.05	0.65
thyroid, fetal, donor1	10060-101H6	102.83	41.40	2.90	1.85	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	67.75	9.24	3.08	0.00	0.00
tongue, adult	10203-103F5	130.94	27.91	1.86	0.70	1.40
tongue, fetal, donor1	10059-101H5	127.29	43.35	1.58	1.58	0.39
tonsil, adult, pool1	10047-101G2	129.53	27.65	1.40	0.40	0.00
trachea, adult, pool1	10029-101E2	194.44	35.58	1.96	0.98	0.25
trachea, fetal, donor1	10058-101H4	179.65	24.24	3.08	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	216.46	10.98	0.00	0.00	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	290.68	20.26	1.52	0.91	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	236.13	11.12	0.94	0.16	0.31
tridermal teratoma cell line:HGRT	10694-109G1	176.94	15.22	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	164.90	18.45	1.35	0.42	0.25
umbilical cord, fetal, donor1	10057-101H3	183.61	33.38	4.17	0.00	2.09
uterus, adult, pool1	10100-102D1	314.98	59.38	7.17	3.41	0.17
uterus, fetal, donor1	10055-101H1	337.87	52.73	5.12	0.51	3.07
vagina, adult	10204-103F6	169.95	36.19	0.00	0.65	0.65
vein, adult	10191-103E2	66.42	26.08	0.22	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	64.09	8.28	0.27	0.00	0.00